Power3 Medical Products, Inc. (OTC:PWRM)
Breast cancer is an uncontrolled growth of breast cells. Cancer occurs as a result of mutations, or abnormal changes, in the genes responsible for regulating the growth of cells and keeping them healthy. The genes are in each cell’s nucleus, which acts as the “control room” of each cell. Normally, the cells in our bodies replace themselves through an orderly process of cell growth: healthy new cells take over as old ones die out. But over time, mutations can “turn on” certain genes and “turn off” others in a cell. That changed cell gains the ability to keep dividing without control or order, producing more cells just like it and forming a tumor.
Power3 Medical Products, Inc., a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States.
Power3 Medical Products Inc. has signed a definitive agreement recently to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. PWRM plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company in the merger.
Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
To learn more about PWRM visit: http://www.Power3Medical.com
Cantel Medical Corp. (NYSE:CMN) recently released the results for its first quarter ended October 31, 2010 and held a conference call to discuss the results. If you are unable to participate, a digital replay of the call is available through midnight, December 16, 2010 by dialing (877) 660-6853 and using pass code # 286 and conference ID # 362463.
Cantel Medical Corp. provides infection prevention and control products in the healthcare market. It operates in six segments: Water Purification and Filtration, Healthcare Disposables, Dialysis, Endoscope Reprocessing, Therapeutic Filtration, and Specialty Packaging. The Water Purification and Filtration segment provides water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage, and commercial industrial markets.
CareFusion Corporation (NYSE:CFN) a leading, global medical device company, announced the launch of SentrySuite, a new set of software applications that improve the quality of patient data and increase clinician productivity and efficiency in pulmonary and cardiopulmonary diagnostic settings. The software focuses on data, organization, workflow and connectivity so physicians can focus more time on patient care. This runs on the CareFusion Jaeger® and SensorMedics® diagnostic devices."Over the past several years, we have worked closely with our global customer base through focus groups, user preference and usability testing to ensure we created a solid foundation for our current and future respiratory diagnostic product portfolio," said Tony Lopez, general manager and senior vice president of Respiratory at CareFusion. "Based on customer feedback, our SentrySuite software is backwards-compatible with existing databases for Jaeger and SensorMedics pulmonary and cardiopulmonary diagnostics devices, allowing clinicians to transfer historical patient records to the new platform and complete patient data comparisons and trend analysis both of which are essential for assessing and developing the best patient treatments possible."
CareFusion Corporation, a medical technology company, provides various healthcare products and services in the United States and internationally. It operates in two segments, Critical Care Technologies, and Medical Technologies and Services. The Critical Care Technologies segment develops, manufactures, and markets equipment and related supplies for infusion, medication and supply dispensing, and respiratory care products.
Orofino Gold Corp. has several Gold development properties in Colombia, a current hot spot of gold production in the world markets. Orofino Gold is please to report that the Board Of Directors have appointed Mr. Ning Shi Long as Chairman of the Board and Executive Director. Mr. Ary Fernando Pernett Marque has been appointed as the new President/CEO & Executive Director of ORFG.
Mr. Pernett will be responsible for all affairs of Orofino Gold in Colombia. Mr. Pernett has 30 years of experience working in the Colombian Mining sector and will over the near term choose his new development team to assist in the development of Orofino Gold’s Senderos de Oro gold camp in the Sur de Bolivar Colombia.
The new team will now aggressively pursue other known Gold occurrences in the companies Senderos de Oro Gold Camp while the development team works to improve production at La Azul Mine. The Board of Director’s have accepted resignation of John T. Martin, former Managing Director of Orofino Gold. His resignation is effective immediately. Orofino Gold wish him well and success in future endeavors.
Orofino Gold and Mr. Pernett will continue to work with Contexto Legal of Medellin and Bogota, Orofino Gold’s legal counsel as well as Discovery Consultants, (The Qualified 43-101 team) Canada, as they have in the past.
Orofino Gold Corp. engages in acquisition, exploration, and development of gold properties in Mexico and Colombia. Orofino Gold has an option to acquire properties in the Sur de Bolivar Department of Colombia South America.
Centene Corp. (NYSE:CNC) completed the purchase of the Medicaid and Long-Term Care Diversion assets of Citrus Health Care, Inc. (Citrus), a managed healthcare services company. With the acquisition, Sunshine State now provides managed care services for over 190,000 Medicaid members as well as for nearly 2,000 Long-Term Care Diversion members in Florida. Sunshine State is working closely with Citrus to ensure a seamless transition for members, providers and other stakeholders.
Centene Corporation operates as a multiline healthcare company in the United States. It operates through two segments, Medicaid Managed Care and Specialty Services. The Medicaid Managed Care segment provides medicaid and medicaid-related health plan coverage to individuals through government subsidized programs, including medicaid, the state children?s health insurance program, foster care, and medicare special needs plans, as well as aged, blind, or disabled (NYSE:ABD) program.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.